Clinical Genomics Laboratory Services

A clinical genomics service provider with comprehensive genomic services to support drug discovery, translational medicine, clinical development, and precision medicine including CDx

Q2 Solutions Genomics Laboratory at a glance:

  • 4 global laboratory locations for genomics services: North Carolina, USA; Beijing, China; Edinburgh, Scotland; Singapore
  • Provided genomics services for 130 different organizations in 2021 
  • 100,000 samples isolated and sequenced annually
  • Received 200,000 samples for processing in 2021
  • 175+ assays
  • 40+ sequencing platforms in operation globally
  • 90+ bioinformaticians and software developers


Our industry-leading genomics team includes:

  • Assay development scientists
  • Bioinformatics scientists
  • Biostatisticians
  • Quality assurance and regulatory personnel 
  • Project management staff certified in PMP and Six Sigma

Q2 Solutions offers a comprehensive Immuno-Oncology Assay Portfolio

We offer a range of genomic laboratory services to support drug discovery, precision medicine and clinical development:

RNA / DNA Sequencing Services

We offers a range of genomic testing services to support drug discovery, precision medicine and clinical development

Single Cell RNA Sequencing

Accelerating research by exploring cellular heterogeneity, tracking population changes, and uncovering molecular interactions

Anatomical Pathology

Comprehensive in-house end-to-end anatomic pathology laboratory, adjunct molecular and histology services are designed to meet your clinical trial needs


Analysis solutions for insights from genomic data

Custom Assay Development

Custom laboratory assay and custom analysis design

Companion Diagnostics

Fulfilling the promise of personalized medicine

Technology Platforms

Platforms for Biomarker Solutions

Quality control (QC) metrics and regulatory standards.

Learn More

Related Thought Leaders Insights

Evaluation of Single Cell RNA Sequencing from FFPE Tissue using 10x Genomics Chromium Gene Expression Flex Assay

Single cell RNA sequencing (scRNA-seq) uncovers tissue heterogeneity by providing gene expression measurements in individual cells within a tissue.  A current limitation of scRNA-seq is the...

Comprehensive Genomic Profiling in FFPE Tissue Sample using TruSight Oncology 500 Assay

Next generation sequencing (NGS)-based comprehensive genomic profiling has emerged as a powerful tool for the large-scale detection of genomic changes. TruSight Oncology 500 (TSO500) Assay employs a...

Single-Cell RNA Profiling of FFPE Tissues

Download this presentation to learn more about a new protocol using Chromium Gene Expression Flex to successfully and reliably conduct single cell RNA sequencing with FFPE tumor biopsy tissues.   ...